nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ALB—hepatitis B	0.166	1	CbGaD
Methotrexate—ABCC4—Adefovir Dipivoxil—hepatitis B	0.116	0.203	CbGbCtD
Methotrexate—ABCC3—Lamivudine—hepatitis B	0.0893	0.156	CbGbCtD
Methotrexate—SLC22A8—Adefovir Dipivoxil—hepatitis B	0.0727	0.127	CbGbCtD
Methotrexate—ABCC4—Lamivudine—hepatitis B	0.0682	0.119	CbGbCtD
Methotrexate—ABCC1—Lamivudine—hepatitis B	0.0548	0.0958	CbGbCtD
Methotrexate—SLC22A6—Adefovir Dipivoxil—hepatitis B	0.0507	0.0885	CbGbCtD
Methotrexate—ABCC2—Lamivudine—hepatitis B	0.0406	0.0709	CbGbCtD
Methotrexate—ABCG2—Lamivudine—hepatitis B	0.0367	0.0641	CbGbCtD
Methotrexate—SLC22A6—Lamivudine—hepatitis B	0.0297	0.0519	CbGbCtD
Methotrexate—ABCB1—Lamivudine—hepatitis B	0.0132	0.0231	CbGbCtD
Methotrexate—Chronic hepatitis—Lamivudine—hepatitis B	0.0111	0.0814	CcSEcCtD
Methotrexate—Immunodeficiency—Entecavir—hepatitis B	0.00831	0.0611	CcSEcCtD
Methotrexate—Hepatitis acute—Telbivudine—hepatitis B	0.00816	0.06	CcSEcCtD
Methotrexate—ABCC3—bile duct—hepatitis B	0.00798	0.127	CbGeAlD
Methotrexate—Hepatic cirrhosis—Entecavir—hepatitis B	0.00752	0.0553	CcSEcCtD
Methotrexate—ABCC2—bile duct—hepatitis B	0.00637	0.102	CbGeAlD
Methotrexate—Hypoxemia—Lamivudine—hepatitis B	0.00332	0.0244	CcSEcCtD
Methotrexate—ATIC—blood plasma—hepatitis B	0.00313	0.0499	CbGeAlD
Methotrexate—Fracture—Adefovir Dipivoxil—hepatitis B	0.00242	0.0178	CcSEcCtD
Methotrexate—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.00242	0.0178	CcSEcCtD
Methotrexate—MTHFR—blood plasma—hepatitis B	0.00233	0.0371	CbGeAlD
Methotrexate—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00206	0.0152	CcSEcCtD
Methotrexate—FOLR1—blood—hepatitis B	0.00203	0.0323	CbGeAlD
Methotrexate—PGD—blood plasma—hepatitis B	0.00202	0.0322	CbGeAlD
Methotrexate—SLCO1B1—blood plasma—hepatitis B	0.00184	0.0292	CbGeAlD
Methotrexate—SLC19A1—blood—hepatitis B	0.00178	0.0283	CbGeAlD
Methotrexate—ABCC3—blood plasma—hepatitis B	0.00174	0.0277	CbGeAlD
Methotrexate—Opportunistic infection—Lamivudine—hepatitis B	0.00166	0.0122	CcSEcCtD
Methotrexate—ABCC11—liver—hepatitis B	0.00152	0.0242	CbGeAlD
Methotrexate—Raised liver function tests—Lamivudine—hepatitis B	0.00144	0.0106	CcSEcCtD
Methotrexate—ABCC4—blood plasma—hepatitis B	0.00144	0.0229	CbGeAlD
Methotrexate—SLC19A1—liver—hepatitis B	0.00139	0.0222	CbGeAlD
Methotrexate—GGH—blood—hepatitis B	0.00135	0.0215	CbGeAlD
Methotrexate—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00132	0.0097	CcSEcCtD
Methotrexate—SLCO4C1—blood—hepatitis B	0.0012	0.019	CbGeAlD
Methotrexate—FPGS—blood—hepatitis B	0.00119	0.0189	CbGeAlD
Methotrexate—Hepatic failure—Entecavir—hepatitis B	0.00116	0.00856	CcSEcCtD
Methotrexate—ATIC—blood—hepatitis B	0.00115	0.0183	CbGeAlD
Methotrexate—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00114	0.00835	CcSEcCtD
Methotrexate—Anaphylactoid reaction—Entecavir—hepatitis B	0.00108	0.00795	CcSEcCtD
Methotrexate—SLC46A1—liver—hepatitis B	0.00107	0.0171	CbGeAlD
Methotrexate—Folliculitis—Lamivudine—hepatitis B	0.00106	0.0078	CcSEcCtD
Methotrexate—GGH—liver—hepatitis B	0.00105	0.0168	CbGeAlD
Methotrexate—Hypoxia—Lamivudine—hepatitis B	0.00105	0.00772	CcSEcCtD
Methotrexate—Sepsis—Telbivudine—hepatitis B	0.00103	0.00755	CcSEcCtD
Methotrexate—Bone marrow depression—Lamivudine—hepatitis B	0.000988	0.00727	CcSEcCtD
Methotrexate—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.000942	0.00693	CcSEcCtD
Methotrexate—SLCO4C1—liver—hepatitis B	0.000935	0.0149	CbGeAlD
Methotrexate—FPGS—liver—hepatitis B	0.000927	0.0148	CbGeAlD
Methotrexate—SLCO1B3—liver—hepatitis B	0.000909	0.0145	CbGeAlD
Methotrexate—ATIC—liver—hepatitis B	0.000897	0.0143	CbGeAlD
Methotrexate—Pancreatitis—Entecavir—hepatitis B	0.000886	0.00652	CcSEcCtD
Methotrexate—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000865	0.00636	CcSEcCtD
Methotrexate—MTHFR—blood—hepatitis B	0.000852	0.0136	CbGeAlD
Methotrexate—Neutropenia—Entecavir—hepatitis B	0.000845	0.00622	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Entecavir—hepatitis B	0.00084	0.00618	CcSEcCtD
Methotrexate—SLCO3A1—blood—hepatitis B	0.000839	0.0134	CbGeAlD
Methotrexate—Renal failure—Entecavir—hepatitis B	0.000792	0.00583	CcSEcCtD
Methotrexate—TYMS—blood—hepatitis B	0.000778	0.0124	CbGeAlD
Methotrexate—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000773	0.00568	CcSEcCtD
Methotrexate—DHFR—blood—hepatitis B	0.00077	0.0123	CbGeAlD
Methotrexate—Haematuria—Entecavir—hepatitis B	0.000768	0.00565	CcSEcCtD
Methotrexate—Hepatobiliary disease—Entecavir—hepatitis B	0.000762	0.00561	CcSEcCtD
Methotrexate—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00075	0.00551	CcSEcCtD
Methotrexate—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000744	0.00547	CcSEcCtD
Methotrexate—PGD—blood—hepatitis B	0.00074	0.0118	CbGeAlD
Methotrexate—Bone disorder—Lamivudine—hepatitis B	0.000738	0.00543	CcSEcCtD
Methotrexate—SLC22A11—liver—hepatitis B	0.000724	0.0115	CbGeAlD
Methotrexate—Hepatitis—Entecavir—hepatitis B	0.000724	0.00532	CcSEcCtD
Methotrexate—Abdominal discomfort—Telbivudine—hepatitis B	0.000712	0.00523	CcSEcCtD
Methotrexate—SLC22A7—liver—hepatitis B	0.000707	0.0113	CbGeAlD
Methotrexate—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000706	0.00519	CcSEcCtD
Methotrexate—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000701	0.00515	CcSEcCtD
Methotrexate—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000697	0.00513	CcSEcCtD
Methotrexate—Neutropenia—Telbivudine—hepatitis B	0.000694	0.00511	CcSEcCtD
Methotrexate—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000692	0.00509	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00069	0.00508	CcSEcCtD
Methotrexate—Inflammation—Lamivudine—hepatitis B	0.000688	0.00506	CcSEcCtD
Methotrexate—Vasculitis—Lamivudine—hepatitis B	0.000683	0.00503	CcSEcCtD
Methotrexate—SLCO1B1—blood—hepatitis B	0.000672	0.0107	CbGeAlD
Methotrexate—MTHFR—liver—hepatitis B	0.000666	0.0106	CbGeAlD
Methotrexate—SLCO3A1—liver—hepatitis B	0.000656	0.0104	CbGeAlD
Methotrexate—Immune system disorder—Entecavir—hepatitis B	0.000654	0.00481	CcSEcCtD
Methotrexate—Renal failure—Telbivudine—hepatitis B	0.000651	0.00479	CcSEcCtD
Methotrexate—Alopecia—Entecavir—hepatitis B	0.000639	0.0047	CcSEcCtD
Methotrexate—ABCC3—blood—hepatitis B	0.000638	0.0102	CbGeAlD
Methotrexate—ABCC10—blood—hepatitis B	0.000635	0.0101	CbGeAlD
Methotrexate—Mental disorder—Entecavir—hepatitis B	0.000634	0.00466	CcSEcCtD
Methotrexate—Malnutrition—Entecavir—hepatitis B	0.00063	0.00463	CcSEcCtD
Methotrexate—Aplastic anaemia—Lamivudine—hepatitis B	0.000626	0.00461	CcSEcCtD
Methotrexate—Hepatobiliary disease—Telbivudine—hepatitis B	0.000626	0.0046	CcSEcCtD
Methotrexate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000615	0.00452	CcSEcCtD
Methotrexate—TYMS—liver—hepatitis B	0.000608	0.00969	CbGeAlD
Methotrexate—Urine output increased—Lamivudine—hepatitis B	0.000603	0.00443	CcSEcCtD
Methotrexate—Mouth ulceration—Lamivudine—hepatitis B	0.000603	0.00443	CcSEcCtD
Methotrexate—DHFR—liver—hepatitis B	0.000602	0.00959	CbGeAlD
Methotrexate—Gynaecomastia—Lamivudine—hepatitis B	0.000597	0.00439	CcSEcCtD
Methotrexate—Back pain—Adefovir Dipivoxil—hepatitis B	0.000594	0.00437	CcSEcCtD
Methotrexate—Hepatitis—Telbivudine—hepatitis B	0.000594	0.00437	CcSEcCtD
Methotrexate—Pharyngitis—Telbivudine—hepatitis B	0.00059	0.00434	CcSEcCtD
Methotrexate—PGD—liver—hepatitis B	0.000579	0.00922	CbGeAlD
Methotrexate—Sepsis—Lamivudine—hepatitis B	0.000579	0.00426	CcSEcCtD
Methotrexate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000568	0.00418	CcSEcCtD
Methotrexate—Lymphadenopathy—Lamivudine—hepatitis B	0.000568	0.00417	CcSEcCtD
Methotrexate—Leukopenia—Entecavir—hepatitis B	0.000564	0.00415	CcSEcCtD
Methotrexate—Polyuria—Lamivudine—hepatitis B	0.000551	0.00405	CcSEcCtD
Methotrexate—SLC16A1—liver—hepatitis B	0.00054	0.00861	CbGeAlD
Methotrexate—Cough—Adefovir Dipivoxil—hepatitis B	0.000536	0.00394	CcSEcCtD
Methotrexate—Mediastinal disorder—Telbivudine—hepatitis B	0.000536	0.00394	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000533	0.00392	CcSEcCtD
Methotrexate—ABCC4—blood—hepatitis B	0.000527	0.00839	CbGeAlD
Methotrexate—SLCO1B1—liver—hepatitis B	0.000526	0.00837	CbGeAlD
Methotrexate—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000523	0.00385	CcSEcCtD
Methotrexate—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000523	0.00385	CcSEcCtD
Methotrexate—SLC22A8—blood—hepatitis B	0.000522	0.00832	CbGeAlD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00052	0.00382	CcSEcCtD
Methotrexate—Malnutrition—Telbivudine—hepatitis B	0.000517	0.0038	CcSEcCtD
Methotrexate—Anaphylactic shock—Entecavir—hepatitis B	0.000514	0.00378	CcSEcCtD
Methotrexate—Infection—Entecavir—hepatitis B	0.000511	0.00376	CcSEcCtD
Methotrexate—AOX1—liver—hepatitis B	0.00051	0.00812	CbGeAlD
Methotrexate—ABCC2—blood—hepatitis B	0.00051	0.00812	CbGeAlD
Methotrexate—Dysgeusia—Telbivudine—hepatitis B	0.000507	0.00373	CcSEcCtD
Methotrexate—Nervous system disorder—Entecavir—hepatitis B	0.000504	0.00371	CcSEcCtD
Methotrexate—Back pain—Telbivudine—hepatitis B	0.0005	0.00368	CcSEcCtD
Methotrexate—ABCB1—blood plasma—hepatitis B	0.0005	0.00797	CbGeAlD
Methotrexate—Skin disorder—Entecavir—hepatitis B	0.000499	0.00367	CcSEcCtD
Methotrexate—ABCC3—liver—hepatitis B	0.000499	0.00794	CbGeAlD
Methotrexate—ABCC10—liver—hepatitis B	0.000496	0.00791	CbGeAlD
Methotrexate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000492	0.00362	CcSEcCtD
Methotrexate—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000491	0.00361	CcSEcCtD
Methotrexate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000487	0.00358	CcSEcCtD
Methotrexate—Ill-defined disorder—Telbivudine—hepatitis B	0.00048	0.00353	CcSEcCtD
Methotrexate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000478	0.00352	CcSEcCtD
Methotrexate—Malaise—Telbivudine—hepatitis B	0.000467	0.00343	CcSEcCtD
Methotrexate—Insomnia—Entecavir—hepatitis B	0.000465	0.00342	CcSEcCtD
Methotrexate—Mood swings—Lamivudine—hepatitis B	0.000459	0.00337	CcSEcCtD
Methotrexate—Somnolence—Entecavir—hepatitis B	0.000457	0.00336	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000457	0.00336	CcSEcCtD
Methotrexate—Dyspepsia—Entecavir—hepatitis B	0.000452	0.00333	CcSEcCtD
Methotrexate—Cough—Telbivudine—hepatitis B	0.000451	0.00332	CcSEcCtD
Methotrexate—ABCC1—blood—hepatitis B	0.000449	0.00715	CbGeAlD
Methotrexate—Liver function test abnormal—Lamivudine—hepatitis B	0.000447	0.00329	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Entecavir—hepatitis B	0.000444	0.00326	CcSEcCtD
Methotrexate—Fatigue—Entecavir—hepatitis B	0.000443	0.00326	CcSEcCtD
Methotrexate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000441	0.00325	CcSEcCtD
Methotrexate—Myalgia—Telbivudine—hepatitis B	0.00044	0.00324	CcSEcCtD
Methotrexate—Chest pain—Telbivudine—hepatitis B	0.00044	0.00324	CcSEcCtD
Methotrexate—Arthralgia—Telbivudine—hepatitis B	0.00044	0.00324	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000437	0.00322	CcSEcCtD
Methotrexate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000436	0.00321	CcSEcCtD
Methotrexate—Discomfort—Telbivudine—hepatitis B	0.000435	0.0032	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000433	0.00318	CcSEcCtD
Methotrexate—SLCO1A2—liver—hepatitis B	0.000428	0.00681	CbGeAlD
Methotrexate—ALB—liver—hepatitis B	0.000425	0.00677	CbGeAlD
Methotrexate—Gastrointestinal pain—Entecavir—hepatitis B	0.00042	0.00309	CcSEcCtD
Methotrexate—Nervous system disorder—Telbivudine—hepatitis B	0.000414	0.00305	CcSEcCtD
Methotrexate—Thrombocytopenia—Telbivudine—hepatitis B	0.000413	0.00304	CcSEcCtD
Methotrexate—ABCC4—liver—hepatitis B	0.000412	0.00656	CbGeAlD
Methotrexate—Pancreatitis—Lamivudine—hepatitis B	0.00041	0.00302	CcSEcCtD
Methotrexate—Skin disorder—Telbivudine—hepatitis B	0.00041	0.00302	CcSEcCtD
Methotrexate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00041	0.00302	CcSEcCtD
Methotrexate—Abdominal pain—Entecavir—hepatitis B	0.000406	0.00299	CcSEcCtD
Methotrexate—Body temperature increased—Entecavir—hepatitis B	0.000406	0.00299	CcSEcCtD
Methotrexate—Abdominal discomfort—Lamivudine—hepatitis B	0.000401	0.00295	CcSEcCtD
Methotrexate—ABCC2—liver—hepatitis B	0.000399	0.00635	CbGeAlD
Methotrexate—Pancytopenia—Lamivudine—hepatitis B	0.000397	0.00292	CcSEcCtD
Methotrexate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000396	0.00292	CcSEcCtD
Methotrexate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000396	0.00292	CcSEcCtD
Methotrexate—Neutropenia—Lamivudine—hepatitis B	0.000391	0.00288	CcSEcCtD
Methotrexate—Dysuria—Lamivudine—hepatitis B	0.000391	0.00288	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000385	0.00283	CcSEcCtD
Methotrexate—Insomnia—Telbivudine—hepatitis B	0.000382	0.00281	CcSEcCtD
Methotrexate—Paraesthesia—Telbivudine—hepatitis B	0.000379	0.00279	CcSEcCtD
Methotrexate—Depression—Lamivudine—hepatitis B	0.000372	0.00274	CcSEcCtD
Methotrexate—Dyspepsia—Telbivudine—hepatitis B	0.000372	0.00273	CcSEcCtD
Methotrexate—ABCG2—blood—hepatitis B	0.000372	0.00592	CbGeAlD
Methotrexate—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00037	0.00272	CcSEcCtD
Methotrexate—Asthenia—Entecavir—hepatitis B	0.000369	0.00271	CcSEcCtD
Methotrexate—Renal failure—Lamivudine—hepatitis B	0.000367	0.0027	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000365	0.00268	CcSEcCtD
Methotrexate—Fatigue—Telbivudine—hepatitis B	0.000364	0.00268	CcSEcCtD
Methotrexate—Stomatitis—Lamivudine—hepatitis B	0.000364	0.00267	CcSEcCtD
Methotrexate—Pain—Telbivudine—hepatitis B	0.000361	0.00266	CcSEcCtD
Methotrexate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00036	0.00265	CcSEcCtD
Methotrexate—Sweating—Lamivudine—hepatitis B	0.000358	0.00263	CcSEcCtD
Methotrexate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000355	0.00261	CcSEcCtD
Methotrexate—Hepatobiliary disease—Lamivudine—hepatitis B	0.000353	0.0026	CcSEcCtD
Methotrexate—Epistaxis—Lamivudine—hepatitis B	0.000352	0.00259	CcSEcCtD
Methotrexate—Diarrhoea—Entecavir—hepatitis B	0.000352	0.00259	CcSEcCtD
Methotrexate—ABCC1—liver—hepatitis B	0.000351	0.00559	CbGeAlD
Methotrexate—Agranulocytosis—Lamivudine—hepatitis B	0.000348	0.00256	CcSEcCtD
Methotrexate—Feeling abnormal—Telbivudine—hepatitis B	0.000348	0.00256	CcSEcCtD
Methotrexate—Gastrointestinal pain—Telbivudine—hepatitis B	0.000345	0.00254	CcSEcCtD
Methotrexate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000343	0.00252	CcSEcCtD
Methotrexate—Dizziness—Entecavir—hepatitis B	0.00034	0.0025	CcSEcCtD
Methotrexate—Hepatitis—Lamivudine—hepatitis B	0.000335	0.00246	CcSEcCtD
Methotrexate—Abdominal pain—Telbivudine—hepatitis B	0.000334	0.00245	CcSEcCtD
Methotrexate—Body temperature increased—Telbivudine—hepatitis B	0.000334	0.00245	CcSEcCtD
Methotrexate—Pharyngitis—Lamivudine—hepatitis B	0.000332	0.00244	CcSEcCtD
Methotrexate—Vomiting—Entecavir—hepatitis B	0.000327	0.0024	CcSEcCtD
Methotrexate—Rash—Entecavir—hepatitis B	0.000324	0.00238	CcSEcCtD
Methotrexate—Dermatitis—Entecavir—hepatitis B	0.000324	0.00238	CcSEcCtD
Methotrexate—Headache—Entecavir—hepatitis B	0.000322	0.00237	CcSEcCtD
Methotrexate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000319	0.00234	CcSEcCtD
Methotrexate—Erythema multiforme—Lamivudine—hepatitis B	0.000317	0.00233	CcSEcCtD
Methotrexate—Rash—Adefovir Dipivoxil—hepatitis B	0.000316	0.00233	CcSEcCtD
Methotrexate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000316	0.00232	CcSEcCtD
Methotrexate—Headache—Adefovir Dipivoxil—hepatitis B	0.000314	0.00231	CcSEcCtD
Methotrexate—Nausea—Entecavir—hepatitis B	0.000305	0.00225	CcSEcCtD
Methotrexate—Asthenia—Telbivudine—hepatitis B	0.000303	0.00223	CcSEcCtD
Methotrexate—Immune system disorder—Lamivudine—hepatitis B	0.000303	0.00222	CcSEcCtD
Methotrexate—Mediastinal disorder—Lamivudine—hepatitis B	0.000302	0.00222	CcSEcCtD
Methotrexate—Chills—Lamivudine—hepatitis B	0.000301	0.00221	CcSEcCtD
Methotrexate—Pruritus—Telbivudine—hepatitis B	0.000299	0.0022	CcSEcCtD
Methotrexate—Nausea—Adefovir Dipivoxil—hepatitis B	0.000298	0.00219	CcSEcCtD
Methotrexate—Alopecia—Lamivudine—hepatitis B	0.000296	0.00218	CcSEcCtD
Methotrexate—Malnutrition—Lamivudine—hepatitis B	0.000292	0.00214	CcSEcCtD
Methotrexate—Erythema—Lamivudine—hepatitis B	0.000292	0.00214	CcSEcCtD
Methotrexate—ABCG2—liver—hepatitis B	0.000291	0.00463	CbGeAlD
Methotrexate—Diarrhoea—Telbivudine—hepatitis B	0.000289	0.00212	CcSEcCtD
Methotrexate—Dysgeusia—Lamivudine—hepatitis B	0.000286	0.0021	CcSEcCtD
Methotrexate—Back pain—Lamivudine—hepatitis B	0.000282	0.00207	CcSEcCtD
Methotrexate—Dizziness—Telbivudine—hepatitis B	0.000279	0.00205	CcSEcCtD
Methotrexate—Ill-defined disorder—Lamivudine—hepatitis B	0.000271	0.00199	CcSEcCtD
Methotrexate—Anaemia—Lamivudine—hepatitis B	0.00027	0.00198	CcSEcCtD
Methotrexate—Vomiting—Telbivudine—hepatitis B	0.000268	0.00197	CcSEcCtD
Methotrexate—Rash—Telbivudine—hepatitis B	0.000266	0.00196	CcSEcCtD
Methotrexate—Dermatitis—Telbivudine—hepatitis B	0.000266	0.00196	CcSEcCtD
Methotrexate—Headache—Telbivudine—hepatitis B	0.000265	0.00195	CcSEcCtD
Methotrexate—Malaise—Lamivudine—hepatitis B	0.000263	0.00193	CcSEcCtD
Methotrexate—Vertigo—Lamivudine—hepatitis B	0.000262	0.00193	CcSEcCtD
Methotrexate—Leukopenia—Lamivudine—hepatitis B	0.000261	0.00192	CcSEcCtD
Methotrexate—Cough—Lamivudine—hepatitis B	0.000254	0.00187	CcSEcCtD
Methotrexate—Convulsion—Lamivudine—hepatitis B	0.000253	0.00186	CcSEcCtD
Methotrexate—Nausea—Telbivudine—hepatitis B	0.000251	0.00184	CcSEcCtD
Methotrexate—Myalgia—Lamivudine—hepatitis B	0.000248	0.00183	CcSEcCtD
Methotrexate—Chest pain—Lamivudine—hepatitis B	0.000248	0.00183	CcSEcCtD
Methotrexate—Arthralgia—Lamivudine—hepatitis B	0.000248	0.00183	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000247	0.00181	CcSEcCtD
Methotrexate—Discomfort—Lamivudine—hepatitis B	0.000245	0.0018	CcSEcCtD
Methotrexate—Confusional state—Lamivudine—hepatitis B	0.00024	0.00176	CcSEcCtD
Methotrexate—Anaphylactic shock—Lamivudine—hepatitis B	0.000238	0.00175	CcSEcCtD
Methotrexate—Infection—Lamivudine—hepatitis B	0.000236	0.00174	CcSEcCtD
Methotrexate—Nervous system disorder—Lamivudine—hepatitis B	0.000233	0.00172	CcSEcCtD
Methotrexate—Thrombocytopenia—Lamivudine—hepatitis B	0.000233	0.00171	CcSEcCtD
Methotrexate—Skin disorder—Lamivudine—hepatitis B	0.000231	0.0017	CcSEcCtD
Methotrexate—Hyperhidrosis—Lamivudine—hepatitis B	0.00023	0.00169	CcSEcCtD
Methotrexate—Anorexia—Lamivudine—hepatitis B	0.000227	0.00167	CcSEcCtD
Methotrexate—Hypotension—Lamivudine—hepatitis B	0.000222	0.00164	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000217	0.00159	CcSEcCtD
Methotrexate—Insomnia—Lamivudine—hepatitis B	0.000215	0.00158	CcSEcCtD
Methotrexate—Paraesthesia—Lamivudine—hepatitis B	0.000214	0.00157	CcSEcCtD
Methotrexate—Dyspnoea—Lamivudine—hepatitis B	0.000212	0.00156	CcSEcCtD
Methotrexate—Somnolence—Lamivudine—hepatitis B	0.000212	0.00156	CcSEcCtD
Methotrexate—Dyspepsia—Lamivudine—hepatitis B	0.000209	0.00154	CcSEcCtD
Methotrexate—Decreased appetite—Lamivudine—hepatitis B	0.000207	0.00152	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000205	0.00151	CcSEcCtD
Methotrexate—Fatigue—Lamivudine—hepatitis B	0.000205	0.00151	CcSEcCtD
Methotrexate—Pain—Lamivudine—hepatitis B	0.000204	0.0015	CcSEcCtD
Methotrexate—Feeling abnormal—Lamivudine—hepatitis B	0.000196	0.00144	CcSEcCtD
Methotrexate—Gastrointestinal pain—Lamivudine—hepatitis B	0.000195	0.00143	CcSEcCtD
Methotrexate—Urticaria—Lamivudine—hepatitis B	0.000189	0.00139	CcSEcCtD
Methotrexate—Abdominal pain—Lamivudine—hepatitis B	0.000188	0.00138	CcSEcCtD
Methotrexate—Body temperature increased—Lamivudine—hepatitis B	0.000188	0.00138	CcSEcCtD
Methotrexate—ABCB1—blood—hepatitis B	0.000183	0.00292	CbGeAlD
Methotrexate—Hypersensitivity—Lamivudine—hepatitis B	0.000175	0.00129	CcSEcCtD
Methotrexate—Asthenia—Lamivudine—hepatitis B	0.000171	0.00126	CcSEcCtD
Methotrexate—Pruritus—Lamivudine—hepatitis B	0.000168	0.00124	CcSEcCtD
Methotrexate—Diarrhoea—Lamivudine—hepatitis B	0.000163	0.0012	CcSEcCtD
Methotrexate—Dizziness—Lamivudine—hepatitis B	0.000157	0.00116	CcSEcCtD
Methotrexate—Vomiting—Lamivudine—hepatitis B	0.000151	0.00111	CcSEcCtD
Methotrexate—Rash—Lamivudine—hepatitis B	0.00015	0.0011	CcSEcCtD
Methotrexate—Dermatitis—Lamivudine—hepatitis B	0.00015	0.0011	CcSEcCtD
Methotrexate—Headache—Lamivudine—hepatitis B	0.000149	0.0011	CcSEcCtD
Methotrexate—ABCB1—liver—hepatitis B	0.000143	0.00228	CbGeAlD
Methotrexate—Nausea—Lamivudine—hepatitis B	0.000141	0.00104	CcSEcCtD
Methotrexate—SLC19A1—Disease—CTNNB1—hepatitis B	3.31e-05	0.000524	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AKR1B1—hepatitis B	3.28e-05	0.000519	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT2—hepatitis B	3.27e-05	0.000517	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CDKN1A—hepatitis B	3.23e-05	0.000512	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PTEN—hepatitis B	3.23e-05	0.00051	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GOT1—hepatitis B	3.18e-05	0.000503	CbGpPWpGaD
Methotrexate—FPGS—Disease—CD4—hepatitis B	3.17e-05	0.000501	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GGT2—hepatitis B	3.15e-05	0.000497	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—ALB—hepatitis B	3.12e-05	0.000494	CbGpPWpGaD
Methotrexate—AOX1—Disease—GOT1—hepatitis B	3.1e-05	0.000491	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT2—hepatitis B	3.08e-05	0.000488	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.07e-05	0.000486	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—hepatitis B	3.06e-05	0.000485	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS2—hepatitis B	3.05e-05	0.000482	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—TGFB1—hepatitis B	3.04e-05	0.00048	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP2A6—hepatitis B	3.03e-05	0.000479	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ALB—hepatitis B	3.01e-05	0.000476	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ALB—hepatitis B	3.01e-05	0.000476	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT2—hepatitis B	3.01e-05	0.000476	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.01e-05	0.000475	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—hepatitis B	2.99e-05	0.000473	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AKR1B1—hepatitis B	2.95e-05	0.000467	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—hepatitis B	2.95e-05	0.000467	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	2.93e-05	0.000464	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—hepatitis B	2.87e-05	0.000454	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.86e-05	0.000452	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	2.85e-05	0.000451	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—ALB—hepatitis B	2.84e-05	0.00045	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGT2—hepatitis B	2.83e-05	0.000448	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ALB—hepatitis B	2.83e-05	0.000447	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT1—hepatitis B	2.82e-05	0.000447	CbGpPWpGaD
Methotrexate—FPGS—Disease—CTNNB1—hepatitis B	2.82e-05	0.000445	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AKR1B1—hepatitis B	2.81e-05	0.000444	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP2A6—hepatitis B	2.76e-05	0.000436	CbGpPWpGaD
Methotrexate—FPGS—Disease—CDKN1A—hepatitis B	2.75e-05	0.000435	CbGpPWpGaD
Methotrexate—FPGS—Disease—PTEN—hepatitis B	2.74e-05	0.000434	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT2—hepatitis B	2.74e-05	0.000433	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN2A—hepatitis B	2.74e-05	0.000433	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTEN—hepatitis B	2.7e-05	0.000427	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—hepatitis B	2.7e-05	0.000427	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGT2—hepatitis B	2.69e-05	0.000425	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFB1—hepatitis B	2.68e-05	0.000423	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—hepatitis B	2.67e-05	0.000423	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GGT1—hepatitis B	2.66e-05	0.000421	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT1—hepatitis B	2.66e-05	0.000421	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP2A6—hepatitis B	2.64e-05	0.000418	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TGFB1—hepatitis B	2.64e-05	0.000417	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	2.63e-05	0.000416	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GGT1—hepatitis B	2.6e-05	0.000411	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT1—hepatitis B	2.6e-05	0.000411	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AKR1B1—hepatitis B	2.6e-05	0.000411	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.59e-05	0.000409	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—F2—hepatitis B	2.54e-05	0.000401	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	2.53e-05	0.000401	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—hepatitis B	2.53e-05	0.000401	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	2.51e-05	0.000397	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—hepatitis B	2.51e-05	0.000397	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—hepatitis B	2.5e-05	0.000396	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT2—hepatitis B	2.5e-05	0.000395	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—hepatitis B	2.49e-05	0.000395	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGT2—hepatitis B	2.49e-05	0.000394	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—hepatitis B	2.47e-05	0.000391	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—hepatitis B	2.45e-05	0.000387	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP2A6—hepatitis B	2.43e-05	0.000384	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT2—hepatitis B	2.39e-05	0.000378	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN2A—hepatitis B	2.39e-05	0.000378	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CCR5—hepatitis B	2.37e-05	0.000375	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT1—hepatitis B	2.37e-05	0.000374	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GGT1—hepatitis B	2.37e-05	0.000374	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—hepatitis B	2.35e-05	0.000371	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—hepatitis B	2.33e-05	0.000369	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—hepatitis B	2.32e-05	0.000367	CbGpPWpGaD
Methotrexate—AOX1—Disease—CCR5—hepatitis B	2.32e-05	0.000367	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HLA-A—hepatitis B	2.31e-05	0.000366	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTEN—hepatitis B	2.3e-05	0.000363	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTEN—hepatitis B	2.3e-05	0.000363	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—hepatitis B	2.29e-05	0.000362	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—hepatitis B	2.28e-05	0.000361	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—hepatitis B	2.27e-05	0.00036	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—hepatitis B	2.26e-05	0.000358	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.26e-05	0.000358	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—hepatitis B	2.26e-05	0.000357	CbGpPWpGaD
Methotrexate—AOX1—Disease—HLA-A—hepatitis B	2.26e-05	0.000357	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN1A—hepatitis B	2.24e-05	0.000354	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	2.23e-05	0.000352	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT2—hepatitis B	2.19e-05	0.000347	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CTNNB1—hepatitis B	2.19e-05	0.000347	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP2A6—hepatitis B	2.19e-05	0.000346	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—hepatitis B	2.19e-05	0.000346	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—hepatitis B	2.18e-05	0.000345	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT1—hepatitis B	2.15e-05	0.000341	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GGT1—hepatitis B	2.15e-05	0.000341	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—hepatitis B	2.15e-05	0.00034	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—hepatitis B	2.15e-05	0.000339	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CDKN1A—hepatitis B	2.14e-05	0.000339	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTEN—hepatitis B	2.14e-05	0.000338	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HSPA5—hepatitis B	2.12e-05	0.000336	CbGpPWpGaD
Methotrexate—DHFR—Disease—CCR5—hepatitis B	2.11e-05	0.000333	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—hepatitis B	2.11e-05	0.000333	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GGT1—hepatitis B	2.06e-05	0.000326	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT1—hepatitis B	2.06e-05	0.000326	CbGpPWpGaD
Methotrexate—DHFR—Disease—HLA-A—hepatitis B	2.05e-05	0.000325	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.04e-05	0.000323	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—hepatitis B	2.02e-05	0.000319	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—hepatitis B	2.01e-05	0.000318	CbGpPWpGaD
Methotrexate—PGD—Disease—CTNNB1—hepatitis B	2.01e-05	0.000317	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT2—hepatitis B	1.98e-05	0.000313	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—hepatitis B	1.96e-05	0.000311	CbGpPWpGaD
Methotrexate—PGD—Disease—CDKN1A—hepatitis B	1.96e-05	0.00031	CbGpPWpGaD
Methotrexate—PGD—Disease—PTEN—hepatitis B	1.96e-05	0.000309	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN1A—hepatitis B	1.95e-05	0.000309	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—hepatitis B	1.94e-05	0.000307	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IFNB1—hepatitis B	1.92e-05	0.000303	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP2A6—hepatitis B	1.91e-05	0.000301	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—hepatitis B	1.9e-05	0.000301	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GGT1—hepatitis B	1.89e-05	0.000299	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT1—hepatitis B	1.89e-05	0.000299	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IFNA1—hepatitis B	1.87e-05	0.000296	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT2—hepatitis B	1.85e-05	0.000293	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—hepatitis B	1.84e-05	0.000291	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—hepatitis B	1.82e-05	0.000289	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTEN—hepatitis B	1.79e-05	0.000283	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—hepatitis B	1.79e-05	0.000283	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—hepatitis B	1.79e-05	0.000283	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.78e-05	0.000281	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—hepatitis B	1.77e-05	0.00028	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IFNA2—hepatitis B	1.74e-05	0.000275	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.73e-05	0.000273	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT2—hepatitis B	1.72e-05	0.000273	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP2A6—hepatitis B	1.71e-05	0.000271	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—hepatitis B	1.71e-05	0.000271	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—hepatitis B	1.71e-05	0.00027	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GGT1—hepatitis B	1.71e-05	0.00027	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT1—hepatitis B	1.71e-05	0.00027	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—hepatitis B	1.69e-05	0.000267	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTEN—hepatitis B	1.64e-05	0.000259	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.63e-05	0.000258	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP2A6—hepatitis B	1.63e-05	0.000258	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—hepatitis B	1.62e-05	0.000256	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKR1B1—hepatitis B	1.6e-05	0.000254	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.6e-05	0.000253	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT1—hepatitis B	1.6e-05	0.000253	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—hepatitis B	1.59e-05	0.000251	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.56e-05	0.000246	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT2—hepatitis B	1.55e-05	0.000245	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—hepatitis B	1.54e-05	0.000243	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT2—hepatitis B	1.54e-05	0.000243	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—hepatitis B	1.52e-05	0.000241	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—hepatitis B	1.52e-05	0.00024	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.52e-05	0.00024	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP2A6—hepatitis B	1.51e-05	0.000239	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	1.5e-05	0.000237	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—hepatitis B	1.49e-05	0.000236	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT1—hepatitis B	1.49e-05	0.000235	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GGT1—hepatitis B	1.49e-05	0.000235	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT2—hepatitis B	1.47e-05	0.000233	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—hepatitis B	1.47e-05	0.000233	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—hepatitis B	1.46e-05	0.00023	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—hepatitis B	1.44e-05	0.000228	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.43e-05	0.000226	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—hepatitis B	1.42e-05	0.000224	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKR1B1—hepatitis B	1.4e-05	0.000222	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.39e-05	0.00022	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.39e-05	0.00022	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.38e-05	0.000219	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—hepatitis B	1.38e-05	0.000219	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT2—hepatitis B	1.36e-05	0.000216	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.36e-05	0.000214	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT2—hepatitis B	1.35e-05	0.000213	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT1—hepatitis B	1.34e-05	0.000212	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGT1—hepatitis B	1.34e-05	0.000212	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	1.34e-05	0.000212	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—hepatitis B	1.34e-05	0.000211	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—hepatitis B	1.33e-05	0.000211	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—hepatitis B	1.33e-05	0.00021	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—hepatitis B	1.32e-05	0.000209	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CTNNB1—hepatitis B	1.32e-05	0.000209	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN1A—hepatitis B	1.29e-05	0.000204	CbGpPWpGaD
Methotrexate—AOX1—Disease—CTNNB1—hepatitis B	1.29e-05	0.000204	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTEN—hepatitis B	1.29e-05	0.000204	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT1—hepatitis B	1.27e-05	0.000201	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGT1—hepatitis B	1.27e-05	0.000201	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN1A—hepatitis B	1.26e-05	0.0002	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTEN—hepatitis B	1.26e-05	0.000199	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—hepatitis B	1.26e-05	0.000199	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—hepatitis B	1.22e-05	0.000193	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.22e-05	0.000193	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—hepatitis B	1.19e-05	0.000189	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGT1—hepatitis B	1.18e-05	0.000186	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT1—hepatitis B	1.18e-05	0.000186	CbGpPWpGaD
Methotrexate—DHFR—Disease—CTNNB1—hepatitis B	1.18e-05	0.000186	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.17e-05	0.000185	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HLA-A—hepatitis B	1.16e-05	0.000184	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.16e-05	0.000183	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.15e-05	0.000182	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1A—hepatitis B	1.15e-05	0.000182	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—F2—hepatitis B	1.15e-05	0.000182	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTEN—hepatitis B	1.15e-05	0.000181	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—hepatitis B	1.15e-05	0.000181	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—hepatitis B	1.13e-05	0.000179	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—hepatitis B	1.1e-05	0.000174	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—hepatitis B	1.1e-05	0.000174	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTEN—hepatitis B	1.08e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.08e-05	0.00017	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—hepatitis B	1.07e-05	0.000169	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTEN—hepatitis B	1.06e-05	0.000167	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—hepatitis B	1.04e-05	0.000165	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—hepatitis B	1.01e-05	0.00016	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—hepatitis B	1.01e-05	0.000159	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTEN—hepatitis B	9.6e-06	0.000152	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—hepatitis B	9.5e-06	0.00015	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	9.48e-06	0.00015	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2A6—hepatitis B	9.31e-06	0.000147	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—hepatitis B	9.09e-06	0.000144	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTEN—hepatitis B	8.74e-06	0.000138	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—hepatitis B	8.42e-06	0.000133	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTEN—hepatitis B	8.38e-06	0.000132	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2A6—hepatitis B	8.16e-06	0.000129	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—hepatitis B	8.06e-06	0.000127	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—hepatitis B	7.91e-06	0.000125	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—hepatitis B	7.87e-06	0.000124	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—hepatitis B	7.73e-06	0.000122	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTEN—hepatitis B	7.68e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—hepatitis B	7.49e-06	0.000119	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—hepatitis B	7.38e-06	0.000117	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—hepatitis B	7.27e-06	0.000115	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—hepatitis B	7.27e-06	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	7.23e-06	0.000114	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—hepatitis B	7.16e-06	0.000113	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—hepatitis B	7.12e-06	0.000113	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTEN—hepatitis B	6.93e-06	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—hepatitis B	6.77e-06	0.000107	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CTNNB1—hepatitis B	6.66e-06	0.000105	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.62e-06	0.000105	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1A—hepatitis B	6.5e-06	0.000103	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTEN—hepatitis B	6.49e-06	0.000103	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—hepatitis B	6.37e-06	0.000101	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—hepatitis B	6.37e-06	0.000101	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—hepatitis B	6.27e-06	9.91e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTEN—hepatitis B	6.04e-06	9.55e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—hepatitis B	6.03e-06	9.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTEN—hepatitis B	5.43e-06	8.59e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—hepatitis B	5.38e-06	8.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTEN—hepatitis B	5.16e-06	8.17e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—hepatitis B	4.97e-06	7.85e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTEN—hepatitis B	4.78e-06	7.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—hepatitis B	4.05e-06	6.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—hepatitis B	3.39e-06	5.36e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTEN—hepatitis B	2.95e-06	4.67e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTEN—hepatitis B	2.58e-06	4.09e-05	CbGpPWpGaD
